Skip to content

Pharyngeal electrical stimulation in patients with neurogenic dysphagia not responding to standard therapy (PES-NOREST): double blind, randomized clinical trial of efficacy.

Pharyngeal electrical stimulation in patients with neurogenic dysphagia not responding to standard therapy (PES-NOREST): double blind, randomized clinical trial of efficacy. - PES-NOREST

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00016845
Enrollment
82
Registered
2019-03-04
Start date
2019-04-03
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

R13.0

Interventions

Group 1: Pharyngeal electrical stimulation
5 stimulation sessions for 10 minutes each
intensity: 75% of tolerance level
1h post stimulation: traditional dysphagia therapy
Group 2: Transcranial direct current stimulation: 5 anodal stimulation sessions over the healthy hemisphere for 10 minutes each
intensity: 1.5 mA
1 h post stimulation: traditional dysphagia therapy
Group 3: Sham: 50% PES, 50% tdcs
5 sessions for 10 minutes each
intensity 0 mA
1 h post sham stimulation: traditional dysphagia therapy

Sponsors

Schön Klinik Bad Aibling
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: -ischemic or hemorrhagic stroke -one-time monohemispheric lesion -positive standardized aspiration screening (modified Evan´s Blue Dye Test (Belafsky et al., 2003); TOR-BSST (Martino et al. 2009)) -Bogenhausener Dysphagie Score 2 (oral diet) =5 -Functional oral intake scale (Crary et al. 2005) FOIS =3 -need for feeding tube or intravenous Infusion -Need for feeding tube + PAS =6 persist 4 weeks post onset -Patient received a minimum of 8 units traditional dysphagia therapy -endoscopically proven aspiration (Penetration-Aspiration Scale PAS =6) for at least one consistency -inpatient at Schön Klinik Bad Aibling

Exclusion criteria

Exclusion criteria: -no informed consent -pre-existing dysphagia -cardiac pacemaker -implanted defibrillator -continuous need for oxygen -pre-existing neurologic or morphologic-anatomic lesions -brainstem or cerebellar lesion -2nd motor neuron n. recurrens lesion -insufficient refelctory cough -oro-pharyngo-esophageal tumors -severe non-substitutional coagulation deficits -partial respiratory insufficiency (Sa02 < 90%) -bradycardia < 50/min -pregnancy -simultaneous inclusion in another clinical trial -delay between FEES at baseline and study inclusion < 7 days -metallic or electronic cerebral implants -skin lesions in the region of stimulation, mainly eczema, psoriasis, dermatitis -epilepsy

Design outcomes

Primary

MeasureTime frame
Change of the Penetration-Aspiration scale (PAS; Rosenbek et al. 1996) for the consistencies saliva, water and puree determinded by flexible endoscopic Evaluation of swallowing (FEES) at baseline and at one week post stimulation.

Secondary

MeasureTime frame
-Yale Residue Scale (Neubauer et al. 2015) -Bogenhausener Dysphagie-scales (BODS1 und BODS2) (Bartolome et al. 2018) -Functional Oral Intake Scale (FOIS) (Crary et al. 2005) -Dysphagia Severity Rating Scale (DSRS) (Jayasekeran et al. 2010) -swallowing frequency during 5 minutes (tactile measurement) -National Institute of Health Stroke Scale (NIHSS) -Barthel Index -Box-Block-Test -Test of Attentional Performance (TAP), Untertest Alertness -Test of Attentional Performance (TAP), Untertest Go/ NoGo Timeline for measurements: baseline, 1 week post stimulation, 3 weeks post stimulation (BODS1, BODS 2, DSRS, FOIS, swallowing frequency, Barthel Index)

Countries

Germany

Contacts

Public ContactFriedemann Müller

Schön Klinik Bad Aibling

fmueller@schoen-kliniken.de08061 903 1503

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026